Health Canada Special Access Program

Editor's note: This story has been updated to clarify that Kelsi Sheren's treatment does not represent the first legal access to medical psilocybin in Canada.  Health Canada’s Special Access Program (SAP) has authorized a physician to provide Apex Labs’ psilocybin macrodose...

Health Canada has approved an amendment to Optimi Health’s (OTCQX: OPTHF) dealer's license, effectively allowing the company to supply MDMA and psilocybin drugs to the country’s Special Access Program (SAP.)  Since Jan. 2022 physicians have been allowed to request...

MDXX-class molecules and clinical-grade MDMA developer PharmAla Biotech and distribution partner Shaman Pharma Corp. (affiliated with GMP-compliant CCrest Labs) received Health Canada’s approval to provide proprietary LaNeo MDMA capsules to a Canadian physician for patient treatment under the...

A patient-led lawsuit against the Canadian government is claiming access to therapeutic psilocybin is a constitutional right under the Canadian Charter of Rights and Freedoms. In 2020, Health Canada started granting Section 56 exemptions for psilocybin-assisted therapy under the federal...

Considering MDMA will likely be the first psychedelic to receive FDA approval for psychotherapeutic use to treat serious mental health conditions such as PTSD, several publicly listed companies are developing related products such as next-generation psychedelics- or a new delivery...

Red Light Holland Moves Full Speed Towards Canadian Controlled Drugs and Substances Dealer's License Ontario-based magic mushrooms producer Red Light Holland Corp. (OTCQB: TRUFF) hired compliance consultants Cannabis License Experts Inc (CLE) to assist with an application for a Controlled Drugs...

The agency regulating all things related to psychedelic-assisted therapy (PAT), Health Canada released a notice to stakeholders on risk-management measures for clinical trials, a seemingly supporting move towards future government-supported access.  As stated, the purpose of notice 22-...

Life sciences biotech company Core One Labs Inc. (OTCQB: CLABF) signed a Letter of Intent with GMP-certified manufacturer Medelys Laboratories International Inc. for the manufacturing of its proprietary psychedelic active pharmaceutical ingredient (API) products. Core One’s subsidiary Vocan...

Legal ketamine-assisted therapy for people with diagnosed mental health conditions continues to expand throughout the U.S. and Canada.  Numinus Wellness Inc. (OTCQX: NUMIF) announced the opening of a second Canada-based clinic in a week offering several therapy modalities for the...

The Neurology Centre of Toronto (NCT), located in a midtown neighborhood and owned by Numinus Wellness Inc. (OTCQX: NUMIF), is offering ketamine-assisted therapy for patients with neurologic conditions diagnoses. Numinus is focused on delivering evidence-based, innovative and safe...

Optimi Health Corp. (OTCQX: OPTHF), the Canadian licensed psychedelic and functional mushrooms producer has signed a partnership agreement with psilocybin patient advocate Thomas Hartle to produce a novel homegrown, natural therapeutic psilocybin product for approved patients. Who Is Thomas...

Two publicly traded psychedelics companies announced supply agreements. HAVN Life Sciences (OTC: HAVLF) will provide mental health clinic MPB Group Inc. with psilocybin-containing mushrooms for its therapeutic retreats in Jamaica and Optimi Health Corp. (OTCQX: OPTHF) will supply...

For those unaware, Canada provides a legal way for patients presenting unresolved mental health issues to receive psychedelic-assisted treatment. While the country still has not provided legal status to psychedelics, recent amendments have made it possible for health practitioners to request...

Braxia Scientific Corp. (CSE: BRAX) (OTC: BRAXF), a medical research company with clinics that provide innovative treatments for people suffering from major depressive disorder and related mental health conditions, has opened a new health clinic in the Kitchener-Waterloo area in Ontario, CA, which...